Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 13, 2018)
  • 8-K (Feb 26, 2018)
  • 8-K (Jan 8, 2018)
  • 8-K (Dec 11, 2017)
  • 8-K (Nov 13, 2017)
  • 8-K (Oct 26, 2017)

 
Other

Encompass Health Corp 8-K 2013

Documents found in this filing:

  1. 8-K
  2. 8-K
2013 Compensation Committee Changes Form 8-K



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): February 14, 2013

HealthSouth Corporation
(Exact name of Registrant as specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-10315
63-0860407
(Commission File Number)
(IRS Employer Identification No.)
 
 
3660 Grandview Parkway, Suite 200, Birmingham, Alabama 35243
(Address of Principal Executive Offices, Including Zip Code)
(205) 967-7116
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

£
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
At the regularly scheduled meetings on February 14-15, 2013, the Board of Directors of HealthSouth Corporation (the “Corporation”), and its Compensation Committee, undertook the customary review and approval of annual compensation decisions. The Compensation Committee oversees the Corporation’s compensation and employee benefit objectives, plans and policies and reviews and approves the compensation of executive officers, except that of the Chief Executive Officer which is ultimately approved by the independent members of the Board of Directors.
The following changes to the compensation of the Corporation’s directors and named executive officers were approved:
increased the non-employee directors’ annual restricted stock unit grant from a value of $100,000 to $115,000, which units are granted at the time annual equity awards are granted to our executives and which units will be settled in shares of our common stock six months following departure from our board;
established the following performance objective metrics for the 2013 annual cash incentive plan and their respective weightings (by percentage of target opportunity value) - the target cash incentive opportunities remain unchanged from 2012:
Named
Executive Officer
Title
Adjusted EBITDA(1)
PEM Score(1)
Individual Objectives
Jay Grinney
President
and Chief Executive Officer
56%
24%
20%
Douglas E. Coltharp
Executive Vice President
and Chief Financial Officer
56%
24%
20%
John P. Whittington
Executive Vice President,
General Counsel and Secretary
56%
24%
20%
Mark J. Tarr
Executive Vice President
and Chief Operating Officer
56%
24%
20%
Dexanne B. Clohan
Chief Medical Officer
49%
21%
30%
established the following target equity award opportunity and equity award types (by percentage of target opportunity value) for the 2013 awards under the long-term incentive plan:
Named
Executive Officer
Title
Total Target Equity Award Opportunity
Options
Performance-based Restricted
Stock

Time-based Restricted
Stock
Jay Grinney
President
and Chief Executive Officer
$
4,999,998

20%
60%
20%
Douglas E. Coltharp
Executive Vice President
and Chief Financial Officer
$
787,515

20%
60%
20%
John P. Whittington
Executive Vice President,
General Counsel and Secretary
$
790,494

20%
60%
20%
Mark J. Tarr
Executive Vice President
and Chief Operating Officer
$
900,013

20%
60%
20%
Dexanne B. Clohan
Chief Medical Officer
$
311,087

60%
40%
established that the performance-based restricted stock, or performance share units (“PSUs”), will be linked to the following 2-year performance metrics: earnings per share (50% of PSUs), return on invested capital (30% of PSUs), and relative total shareholder return (“TSR”) (20% of PSUs).(1) As in prior years, the shares earned at the end of the related performance period will, assuming continuing employment, fully vest one year thereafter.





reinstituted the relative TSR component of the performance-based restricted stock, which will be measured using the healthcare provider peer group currently used for compensation benchmarking and structured as follows:
Restricted Stock Achievement Level
2-Year Relative Performance Against Peer Group
Payout Multiple
(% of Target)
Maximum
≥80th Percentile
200%
Target
50th Percentile
100%
Threshold
30th Percentile
50%
Not eligible
<30th Percentile
Healthcare Provider Peer Group
Amedisys
Health Management Associates
Skilled Healthcare Group
Chemed Corporation
Kindred Healthcare
Tenet Healthcare
Community Health Systems
LifePoint Hospitals
Universal Healthcare Services
Gentiva Health Services
Select Medical Holdings
 
The Corporation’s executive compensation plans and arrangements are otherwise described in the section captioned “Executive Compensation” in its Definitive Proxy Statement on Schedule 14A filed on April 2, 2012.
(1)
There have been no material changes to the Adjusted EBITDA, earnings per share, and return on invested capital performance metrics or the calculations thereof as defined and described in the section captioned “Compensation Discussion and Analysis” in the Corporation's Definitive Proxy Statement on Schedule 14A filed on April 2, 2012. “PEM Score” means the company-wide program evaluation model, or PEM, score, an industry standard quality metric that evaluates the functional gains of patients achieved during their hospital stay and the discharge status of patients. PEM Scores from all of the Corporation’s hospitals are submitted to the Uniform Data System for Medical Rehabilitation database. The PEM Score performance objective is a target percentage of the Corporation’s hospitals for which the reported PEM Scores meet their respective pre-determined PEM Score goals. “Total shareholder return” means the annualized rate of return reflecting (a) price appreciation of a share of common stock during the performance period based on the average closing price of that share for the sixty (60) trading days immediately prior to the performance period and the last sixty (60) trading days of the performance period and (b) any and all per share dividends distributed during the performance period.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHSOUTH CORPORATION
 
 
 
By:
/S/   JOHN P. WHITTINGTON
 
Name:
John P. Whittington
 
Title:
Executive Vice President, General Counsel
and Corporate Secretary

Dated: February 20, 2013




Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki